| 2024 |
The Consistency and Quality of ChatGPT Responses Compared to Clinical Guidelines for Ovarian Cancer: A Delphi Approach |
Articolo in rivista |
Vai |
| 2024 |
The Impact of Neoadjuvant Chemotherapy on Axillary Surgical Management of Patients With Breast Cancer and Positive Axillary Lymph Nodes |
Articolo in rivista |
Vai |
| 2024 |
Evaluation of predictive factors for i-CLARAS (intraoperative complications in laparoscopic renal and adrenal surgery): a multicentre international retrospective cohort study |
Articolo in rivista |
Vai |
| 2024 |
Correlation between sentinel lymph node biopsy and non-sentinel lymph node metastasis in patients with cN0 breast carcinoma: comparison of invasive ductal carcinoma and invasive lobular carcinoma |
Articolo in rivista |
Vai |
| 2024 |
A Survey on Knowledge and Attitudes Towards Vaccination Against Herpes Zoster Virus Among Medical Oncologists for Patients with Solid Tumors |
Articolo in rivista |
Vai |
| 2024 |
Immune checkpoint inhibitor therapy‑related pneumonitis: How, when and why to diagnose and manage (Review) |
Review essay (rassegna critica) |
Vai |
| 2024 |
Correction to: Real-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancer (npj Breast Cancer |
Articolo in rivista |
Vai |
| 2024 |
Abemaciclib pharmacology and interactions in the treatment of HR+/HER2− breast cancer: a critical review |
Review essay (rassegna critica) |
Vai |
| 2024 |
A review and metanalysis of metronomic oral single-agent cyclophosphamide for treating advanced ovarian carcinoma in the era of precision medicine |
Articolo in rivista |
Vai |
| 2024 |
Abemaciclib pharmacology and interactions in the treatment of HR+/HER2− breast cancer: a critical review |
Articolo in rivista |
Vai |
| 2024 |
Comprehensive Axillary Management of Clinically Node-Positive (cN plus ) Breast Cancer Patients: A Narrative Review on Neoadjuvant Chemotherapy |
Review essay (rassegna critica) |
Vai |
| 2024 |
Surviving Twenty Years to Bone and Liver Metastatic Breast Cancer: A Case Reported by Treating Oncologists and the Patient Herself |
Articolo in rivista |
Vai |
| 2024 |
Unveiling the Intricate Dance: How Cancer Orchestrates Muscle Wasting and Sarcopenia |
Articolo in rivista |
Vai |
| 2024 |
New Frontiers in the Treatment of Patients with HER2+ Cancer and Brain Metastases: Is Radiotherapy Always Useful? |
Articolo in rivista |
Vai |
| 2023 |
A retrospective, real-life analysis of metronomic oral single-agent cyclophosphamide for the treatment of platinum-pretreated advanced ovarian carcinoma in Italy |
Articolo in rivista |
Vai |
| 2023 |
Adjuvant capecitabine in triple negative breast cancer patients with residual disease after neoadjuvant treatment: real-world evidence from CaRe, a multicentric, observational study |
Articolo in rivista |
Vai |
| 2023 |
Breast Cancer in Two Ex-Votos, A Millennia Apart: Patients' Hope and Faith Expressed Through the Centuries in Votive Offerings |
Articolo in rivista |
Vai |
| 2023 |
Real-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancer |
Articolo in rivista |
Vai |
| 2023 |
Breast Cancer in Two Ex‑Votos, A Millennia Apart: Patients’
Hope and Faith Expressed Through the Centuries in Votive
Offerings |
Articolo in rivista |
Vai |
| 2023 |
Final results of the real-life observational VICTOR-6 study on metronomic chemotherapy in elderly metastatic breast cancer (MBC) patients |
Articolo in rivista |
Vai |
| 2023 |
Abemaciclib-associated Diarrhea: An Exploratory Analysis of Real-life Data |
Articolo in rivista |
Vai |
| 2023 |
Outcomes of Sentinel Lymph Node Biopsy for Patients With Node-positive Breast Cancer Treated With Neoadjuvant Chemotherapy |
Articolo in rivista |
Vai |
| 2023 |
Letter to the Editor: statistics and clinical perception of patients' reported outcomes for palbociclib and abemaciclib: a sliding doors story |
Lettera |
Vai |
| 2023 |
Author Correction: Real-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancer (npj Breast Cancer |
Articolo in rivista |
Vai |
| 2022 |
A Prospective Observational Study on the Structuring Process and Implementation of a Large Regional, Inter-hospital, Virtual Multidisciplinary Tumor Board on Prostate Cancer |
Articolo in rivista |
Vai |
| 2022 |
Stereotactic Radiotherapy in Early-Stage Breast Cancer in Neoadjuvant and Exclusive Settings: A Systematic Review |
Articolo in rivista |
Vai |
| 2021 |
PANHER study: a 20-year treatment outcome analysis from a multicentre observational study of HER2-positive advanced breast cancer patients from the real-world setting |
Articolo in rivista |
Vai |
| 2021 |
WhatsApp Messenger use in oncology: a narrative review on pros and contras of a flexible and practical, non-specific communication tool |
Articolo in rivista |
Vai |
| 2021 |
A Case of Follicular Tumor of Uncertain Malignant Potential (FT-UMP) with Glomeruloid Features Showing Capsular Mucinous Degeneration |
Articolo in rivista |
Vai |
| 2021 |
Eribulin Mesylate for the Treatment of Metastatic Hormone-refractory and Triple-negative Breast Cancer: A Multi-institutional Real-world Report on Efficacy and Safety |
Articolo in rivista |
Vai |
| 2021 |
Oral vinorelbine and capecitabine as first-line therapy in metastatic breast cancer: a retrospective analysis |
Articolo in rivista |
Vai |
| 2021 |
Harmful Interference of Detoxifying Diets and Nutraceuticals with Adherence to Abemaciclib in Advanced Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor-2-Negative Breast Cancer: A Case Report |
Articolo in rivista |
Vai |
| 2021 |
Effects of the number of removed lymph nodes on survival outcome in patients with sentinel node-negative breast cancer |
Articolo in rivista |
Vai |
| 2021 |
Second-line Eribulin in Triple Negative Metastatic Breast Cancer patients. Multicentre Retrospective Study: The TETRIS Trial |
Articolo in rivista |
Vai |
| 2021 |
Metronomic chemotherapy (mCHT) in metastatic triple-negative breast cancer (TNBC) patients: results of the VICTOR-6 study |
Articolo in rivista |
Vai |
| 2021 |
The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial |
Articolo in rivista |
Vai |
| 2021 |
Virtual Multidisciplinary Tumor Boards: A Narrative Review Focused on Lung Cancer |
Articolo in rivista |
Vai |
| 2021 |
Fulvestrant and trastuzumab in patients with luminal HER2-positive advanced breast cancer (ABC): an Italian real-world experience (HERMIONE 9) |
Articolo in rivista |
Vai |
| 2020 |
Gastric metastasis from breast cancer |
Articolo in rivista |
Vai |
| 2020 |
Does Smoking Cessation at Primary Diagnosis Reduce the Recurrence Risk of Nonmuscle-Invasive Bladder Cancer? Results of a Prospective Study |
Articolo in rivista |
Vai |
| 2020 |
Loss of HER2 and decreased T-DM1 efficacy in HER2 positive advanced breast cancer treated with dual HER2 blockade: the SePHER Study |
Articolo in rivista |
Vai |
| 2020 |
Stereotactic Radiotherapy for the Treatment of Patients With Oligo-progressive Metastatic Renal Cell Carcinoma Receiving Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor: Data From the Real World |
Articolo in rivista |
Vai |
| 2020 |
Patients With Cancer and COVID-19: A WhatsApp Messenger-Based Survey of Patients' Queries, Needs, Fears, and Actions Taken |
Articolo in rivista |
Vai |
| 2020 |
Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence |
Articolo in rivista |
Vai |
| 2020 |
Is G8 geriatric assessment tool useful in managing elderly patients with metastatic pancreatic carcinoma? |
Articolo in rivista |
Vai |
| 2020 |
Abemaciclib: safety and effectiveness of a unique cyclin-dependent kinase inhibitor |
Articolo in rivista |
Vai |
| 2020 |
Metronomic oral vinorelbine in patients with advanced non-small cell lung cancer progressing after nivolumab immunotherapy: a retrospective analysis |
Articolo in rivista |
Vai |
| 2020 |
High-dose Radiotherapy for Oligo-progressive NSCLC Receiving EGFR Tyrosine Kinase Inhibitors: Real World Data |
Articolo in rivista |
Vai |
| 2020 |
Lapatinib activity in a patient with encephalic metastases from trastuzumab-resistant her-2 positive breast cancer |
Articolo in rivista |
Vai |
| 2020 |
Impressive objective response to nab-paclitaxel plus trastuzumab as fifth line therapy in aelderly her2-positive breast cancer patient |
Articolo in rivista |
Vai |
| 2020 |
Axillary Nodal Burden in Breast Cancer Patients With Pre-operative Fine Needle Aspiration-proven Positive Lymph Nodes Compared to Those With Positive Sentinel Nodes |
Articolo in rivista |
Vai |
| 2020 |
Current Role of Intraoperative Frozen Section Examination of Sentinel Lymph Node in Early Breast Cancer |
Articolo in rivista |
Vai |
| 2020 |
NEPA as antiemetic prophylaxis after failure of 5HT3-RA plus dexamethasone in patients receiving carboplatin and gemcitabine chemotherapy: A monocentric real-life experience |
Articolo in rivista |
Vai |
| 2019 |
Is There Still a Role for Endocrine Therapy Alone in HR+/HER2- Advanced Breast Cancer Patients? Results from the Analysis of Two Data Sets of Patients Treated with High-Dose Fulvestrant as First-Line Therapy in the Real-World Setting: The EVA and GIM-13 AMBRA Studies |
Articolo in rivista |
Vai |
| 2019 |
Metronomic chemotherapy for advanced breast cancer patients in the real world practice: Final results of the VICTOR-6 study |
Articolo in rivista |
Vai |
| 2019 |
Radium-223 treatment in castration resistant bone metastatic prostate cancer. Should be the primary tumor always treated? |
Articolo in rivista |
Vai |
| 2019 |
Management of toxicities associated with targeted therapies for HR-positive metastatic breast cancer: a multidisciplinary approach is the key to success |
Review essay (rassegna critica) |
Vai |
| 2018 |
Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: New lessons for clinical practice from the EVA study |
Articolo in rivista |
Vai |
| 2018 |
Hematologic toxicity of radium-223 in elderly patients with metastatic Castration Resistant Prostate Cancer: a real-life experience |
Articolo in rivista |
Vai |
| 2017 |
Gastric and Rectal Metastases from Malignant Melanoma Presenting with Hypochromic Anemia and Treated with Immunotherapy |
Articolo in rivista |
Vai |
| 2017 |
Metronomic Chemotherapy (mCHT) in HER2-ve Advanced Breast Cancer (ABC) Patients (PTS): When Care Objectives Meet Patients’ Need. Preliminary Results of the Victor-6 Study |
Abstract in atti di convegno pubblicato in rivista |
Vai |
| 2017 |
Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2−) advanced breast cancer patients: New insights beyond clinical trials. The EVA study |
Articolo in rivista |
Vai |
| 2017 |
The HERBA trial: a retrospective study on patients (pts) with HER2-positive (HER2+ve) breast cancer (BC) and brain metastases (BMs) |
Abstract in atti di convegno pubblicato in rivista |
Vai |
| 2017 |
Metronomic chemotherapy (mCHT) in HER2-ve advanced breast cancer (ABC) patients (pts): What has changed over the time? Preliminary results of the VICTOR-6 study |
Abstract in atti di convegno pubblicato in rivista |
Vai |
| 2015 |
Time to initiation of adjuvant chemotherapy in patients with rapidly proliferating early breast cancer |
Articolo in rivista |
Vai |
| 2012 |
Adherence, compliance and persistence to oral antineoplastic therapy: A review focused on chemotherapeutic and biologic agents |
Articolo in rivista |
Vai |
| 2012 |
Oral metronomic cyclophosphamide with and without methotrexate as palliative treatment for patients with metastatic breast carcinoma |
Articolo in rivista |
Vai |
| 2012 |
Phase I-II trial of gemcitabine-based first-line chemotherapies for small cell lung cancer in elderly patients with performance status 0-2: The G-Step trial |
Articolo in rivista |
Vai |
| 2011 |
Cigarette smoking habit does not reduce the benefit from first line trastuzumab-based treatment in advanced breast cancer patients |
Articolo in rivista |
Vai |
| 2011 |
Salvage Therapy With Oral Metronomic Cyclophosphamide and Methotrexate for Castration refractory Metastatic Adenocarcinoma
of the Prostate Resistant to Docetaxel |
Articolo in rivista |
Vai |
| 2011 |
Metastatic seeding of colon adenocarcinoma manifesting as synchronous breast and chest wall localization: report of a case. |
Articolo in rivista |
Vai |
| 2011 |
Carboplatin plus paclitaxel versus carboplatin plus pegylated liposomal doxorubicin as first-line treatment for patients with ovarian cancer: The MITO-2 randomized phase III trial |
Articolo in rivista |
Vai |
| 2011 |
Italian Survey on adjuvant treatment of non-small cell lung cancer (ISA) |
Articolo in rivista |
Vai |
| 2011 |
Randomized phase III trial of adjuvant epirubicin followed by cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) versus CMF followed by epirubicin in patients with node-negative or 1-3 node-positive rapidly proliferating breast cancer |
Articolo in rivista |
Vai |
| 2011 |
Effects of hypolipidemic and hypoglycemic
agents on atherogenic small, dense LDL in
Type 2 diabetes |
Articolo in rivista |
Vai |
| 2010 |
Cetuximab and gemcitabine in elderly or adult PS2 patients with advanced
non-small-cell lung cancer: The cetuximab in advanced lung cancer (CALC1-E and
CALC1-PS2) randomized phase II trials. |
Articolo in rivista |
Vai |
| 2010 |
RUOLO DELL’ECOCOLOR DOPPLER TISSUTALE NELLA VALUTAZIONE DELLA CARDIOTOSSICITÀ DA CHEMIOTERAPICI |
Proceedings |
Vai |
| 2009 |
L'impiego del Tachosil in chirurgia epatica |
Articolo in rivista |
Vai |
| 2007 |
Alexithymia and copyng style in women going to visit in a breast cancer center |
Proceedings |
Vai |
| 2007 |
Safety and activity of trastuzumab-containing therapies for the treatment of metastatic breast cancer: our long-term clinical experience (GOIM study). |
Abstract in rivista |
Vai |
| 2007 |
Circulating VEGF reduction, response and outcome in advanced colorectal cancer patients treated with cetuximab plus irinotecan |
Articolo in rivista |
Vai |
| 2007 |
Alexithymia and coping style in women going to visit in a breast cancer center. |
Proceedings |
Vai |
| 2007 |
Liposomal-encapsulated doxorubicin plus cyclophosphamide as first-line therapy in metastatic breast cancer: a phase II multicentric study |
Articolo in rivista |
Vai |
| 2007 |
Docetaxel and oxaliplatin in the second-line treatment of platinum-sensitive recurrent ovarian cancer: a phase II study. |
Articolo in rivista |
Vai |
| 2006 |
A new germline mutation in BRCA1 gene in a sicilian family with ovarian cancer. |
Articolo in rivista |
Vai |
| 2006 |
RELATIONSHIP BETWEEN THYMIDYLATE SYNTHASE EXPRESSION AND p53 LEVELS WITH THE TREATMENT BY CYCLOPHOSPHAMIDE, 5-FLUOROURACIL CHEMOTHERAPY (CMF) VERSUS DOCETAXEL IN THE LOCALLY ADVANCED CARCINOMA OF THE BREAST. |
Proceedings |
Vai |
| 2006 |
Residual neurotoxicity in ovarian cancer patients in clinical remission after
first-line chemotherapy with carboplatin and paclitaxel: the Multicenter Italian
Trial in Ovarian cancer (MITO-4) retrospective study. |
Articolo in rivista |
Vai |
| 2006 |
STUDIO DI FASE II: DOCETAXEL SETTIMANALE COME SECONDA LINEA CHEMIOTERAPICA NEL CARCINOMA PROSTATICO AVANZATO |
Proceedings |
Vai |
| 2006 |
Low dose oral chemotherapy for hormone refractory prostate carcinoma estramustine phosphate versus estramustine phosphate and etoposide. A Randomized phase II study of GSTU foundation |
Proceedings |
Vai |
| 2006 |
Gemcitabine and oxaliplatin combination chemotherapy in advanced biliary tract cancers |
Articolo in rivista |
Vai |
| 2006 |
TP53 mutations and S-phase fraction but not DNA-ploidy are independent prognostic indicators in laryngeal squamous cell carcinoma |
Articolo in rivista |
Vai |
| 2006 |
Significance of P16INK4A hypermethylation gene in primary head/neck and colorectal tumors: it is a specific tissue event? Results of a 3-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study |
Articolo in rivista |
Vai |
| 2006 |
Relationship between thymidylate synthase expression and p53 levels with the treatment of cyclophsphamide, methotrexate, 5-fluorouracil chemotherapy ( CMF)versus docetaxel ( TXT) in locally advanced carcinoma of the breast |
Proceedings |
Vai |
| 2006 |
A phase II study of pegylated liposomal doxorubicin oxaliplatin and cyclophosphamide as second-line treatment in relapsed ovarian carcinoma |
Articolo in rivista |
Vai |
| 2006 |
Studio di phase II: Docetaxel settimanale come seconda linea chemioterapia nel carcinoma prostatico avanzato. |
Proceedings |
Vai |
| 2006 |
Relationship between the thymidylate synthase, p53 levels with the treatment by Cyclophosphamide, Metotrexate, 5-Fluorouracil chemotherapy (CMF) versus Docetaxel (TXT) in the locally advanced carcinoma of breast. |
Proceedings |
Vai |
| 2006 |
Y179C, F486L and N550H are BRCA1 variants that may be associated with breast cancer in a Sicilian family: results of a 5-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study |
Articolo in rivista |
Vai |
| 2006 |
Molecular detection of TP53, Ki-Ras and p16INK4A promoter methylation in plasma of patients with colorectal cancer and its association with prognosis. Results of a 3-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study. |
Articolo in rivista |
Vai |
| 2006 |
Detection and quantification of mammaglobin in the blood of breast cancer patients: can it be useful as a potential clinical marker? Preliminary results of a GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study. |
Articolo in rivista |
Vai |
| 2006 |
Clinical presentation and treatment of gastrointestinal stromal tumors. |
Articolo in rivista |
Vai |
| 2005 |
The use of zoledronic acid in patients with bone metastases from prostate carcinoma: effect on analgesic response and bone metabolism biomarkers |
Articolo in rivista |
Vai |
| 2005 |
TP53 mutations are not prognostic indipendent indicators in bladder cancer |
Proceedings |
Vai |
| 2005 |
Analysis of Ki-ras mutations in stage I rectal carcinomas and respective regional lymphonodes |
Proceedings |
Vai |
| 2005 |
TP53 mutations and S-Phase fraction are independent prognostic indicators in locally advanced laryngeal squamous cell carcinoma |
Altro |
Vai |
| 2005 |
Specific TP53 and/or Ki-ras mutations as independent predictors of clinical
outcome in sporadic colorectal adenocarcinomas: results of a 5-year Gruppo
Oncologico dell'Italia Meridionale (GOIM) prospective study. |
Articolo in rivista |
Vai |
| 2005 |
The prognostic role of TP53 mutations in advanced laryngeal squamous cell carcinoma (LSCC). |
Proceedings |
Vai |
| 2005 |
The Use of Gemcitabine in heavily pretreted breast cancer patients |
Proceedings |
Vai |
| 2005 |
Mutational analysis of BRCA1 gene in sicilian patient at risk for inherited breast and/or ovarian cancer: experience of reference center the biomolecular characterization of neoplasm and genetic screening of hereditary tumors. |
Proceedings |
Vai |
| 2005 |
Home therapy for deep vein thrombosis and pulmonary embolism in cancer patients |
Articolo in rivista |
Vai |
| 2005 |
Mutational analysis of BRCA1 gene in sicilian patients at risk for inherited breast and/or ovarian cancer: experience of reference centre for the biomolecular characterization of neoplasms and genetic screening of hereditary tumors. |
Proceedings |
Vai |
| 2005 |
TP53 Mutation in exon 5 and S-Phase Fraction but not Mutations in Ras gene family and DNA-ploidy are Indipendent prognostic indicators in Laryngeal Squamous Cell Carcinoma |
Proceedings |
Vai |
| 2005 |
TP53 mutations are not prognostic independent indicators in bladder cancer. |
Proceedings |
Vai |
| 2005 |
Phase III randomized trial of FOLFIRI versus FOLFOX4 in the treatment of
advanced colorectal cancer: a multicenter study of the Gruppo Oncologico
Dell'Italia Meridionale |
Articolo in rivista |
Vai |
| 2005 |
A.Mutational analysis of BRCA1 in sicilian patients at risk for inherited of reference center for the biomolecular characterizaztion of neoplasm and genetic screening of hereditary tumors |
Proceedings |
Vai |
| 2005 |
Detection of free-circulating tumor DNA in plasma of patients with gastrointestinal cancer. |
Proceedings |
Vai |
| 2005 |
A phase II study of oxaliplatin (O) and gemcitabine (G) first line chemotherapy in patients with advanced biliary tract cancers |
Proceedings |
Vai |
| 2004 |
Detection and clinical relevance of free-circulating tumor DNA in blood of patients with colorectal cancer. Proceeding of ICACT Fifteenth International Congress on Anticancer Treatment February 9th 12th 2004, Paris accepted for oral presentation |
Proceedings |
Vai |
| 2004 |
Novel association with gemcitabine and docetaxel as salvage chemotherapy in metastatic breast cancer previously treated with anthracyclines: results of a multicenter phase II study |
Articolo in rivista |
Vai |
| 2004 |
Terapia di seconda linea del carcinoma gastrico avanzato con la combinazione Irinotecan (Cpt 11) + Mitomicina (MMc). Studio di fase II del Gruppo Oncologico dell’Italia Meridionale (prot. GOIM 2106) VII CONGRESSO NAZIONALE G.O.I.M. ROMA 23-25 Giugno 2004 |
Proceedings |
Vai |
| 2004 |
TP53 in gastric cancer: mutations in the l3 loop and LSH motif DNA-binding domains of TP53 predict poor outcome |
Articolo in rivista |
Vai |
| 2004 |
Pegylated Liposomal Doxorubicin and weekly paclitaxel as first line treatment in metastatic breast cancer |
Proceedings |
Vai |
| 2004 |
Mitoxantrone + Prednisone versus Taxotere + Prednisone nel trattamento del carcinoma prostatico ormonorefrattario (cpor ). Studio randomizzato di fase II del Gruppo Oncologico dell’Italia Meridionale (GOIM ). VII CONGRESSO NAZIONALE G.O.I.M. ROMA 23-25 Giugno 2004 |
Proceedings |
Vai |
| 2004 |
Cardiotossicità e Cardioprotezione. |
Altro |
Vai |
| 2004 |
GRUPPO ONCOLOGICO ITALIA MERIDIONALE. NOVEL ASSOCIATION WITH GEMCITABINE AND DOCETAXEL AS SALVAGE CHEMOTHERAPY IN METASTATIC BREAST CANCER PREVIOUSLY TREATED WITH ANTHRACYCLINES: RESULT OF A NULTICENTER PHASE II STUDY |
Articolo in rivista |
Vai |
| 2004 |
Topotecan compared with no terapy and carboplatin/paclitaxel in patients with ovarian cancer: Multicenter Italian Trials in Ovarian Cancer (MITO-1) randomized study |
Articolo in rivista |
Vai |
| 2004 |
A phase 2 study of Oxaliplatin ( O ) – Capecitabine( C ) chemotherapy in metastatic breast cancer ( MBC ) patients pretreated with Anthracyclines and taxanes VII CONGRESSO NAZIONALE G.O.I.M. ROMA 23-25 Giugno 2004 |
Proceedings |
Vai |
| 2004 |
Detection and clinical relevance of free-circulating tumor DNA in blood of patients with colorectal cancer |
Proceedings |
Vai |
| 2004 |
A phase II study of capecitabine oxaliplatin chemotherapy in metastatic breast cancer patients pretreated with anthracyclines and taxanes |
Proceedings |
Vai |
| 2004 |
Weekly Paclitaxel (T) and pegylated liposomal Doxorubicin (PLD) as first line treatment in metastatic breast cancer (MBC) patients.VII CONGRESSO NAZIONALE G.O.I.M. ROMA 23-25 Giugno 2004 |
Proceedings |
Vai |
| 2004 |
Epirubicina (EPI ) e Docetaxel (DOC ) come chemioterapia primaria ( C P ) nel trattamento del carcinoma mammario localmente avanzato ( CMLA ). VII CONGRESSO NAZIONALE G.O.I.M. ROMA 23-25 Giugno 2004 |
Proceedings |
Vai |
| 2002 |
DNA ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective study |
Articolo in rivista |
Vai |
| 2002 |
p53 mutations in L3-loop zinc-binding domain, DNA-ploidy, and S phase fraction are independent prognostic indicators in colorectal cancer: A prospective study with a five-year follow-up |
Articolo in rivista |
Vai |
| 2001 |
DNA aneuploidy and high proliferative activity but not K-ras-2 mutations as independent predictors of clinical outcome in operable gastric carcinoma: Results of a 5-year Gruppo Oncologico dell'Italia Meridionale (GOIM) prospective study |
Articolo in rivista |
Vai |
